These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4406492)

  • 21. Diabetes mellitus in chronic active hepatitis and cirrhosis.
    Kingston ME; Ali MA; Atiyeh M; Donnelly RJ
    Gastroenterology; 1984 Sep; 87(3):688-94. PubMed ID: 6086443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Measurement of plasma insulin and growth hormone after oral glucose tolerance test in patients with alcoholic cirrhosis].
    Descos L; M'Bendi S; Sassolas G; Audigier JC; Sidiqian N; Faure A; Bizollon CA
    Arch Fr Mal App Dig; 1974; 63(1):17-24. PubMed ID: 4441222
    [No Abstract]   [Full Text] [Related]  

  • 23. Carbohydrate intolerance in idiopathic haemochromatosis and cirrhosis of the liver.
    Stocks AE; Powell LW
    Q J Med; 1973 Oct; 42(168):733-49. PubMed ID: 4802417
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prevalence and clinical significance of diabetes mellitus in patients with liver cirrhosis].
    Kwon SY
    Taehan Kan Hakhoe Chi; 2003 Sep; 9(3):205-11. PubMed ID: 14515038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between human growth hormone and the development of diabetes mellitus and its complications.
    Baird JD; Hunter WM; Smith AW
    Postgrad Med J; 1973 Feb; 49 Suppl 1():132-40. PubMed ID: 4728412
    [No Abstract]   [Full Text] [Related]  

  • 26. Cirrhosis and diabetes. IV. Effect of potassium chloride administration on glucose and insulin metabolism.
    Conn HO
    Am J Med Sci; 1970 Jun; 259(6):394-404. PubMed ID: 5422283
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hepatogenic diabetes: pathophysiology, therapeutic options and prognosis].
    Petrides AS
    Z Gastroenterol; 1999 Jun; Suppl 1():15-21. PubMed ID: 10444811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of pituitary gland in diabetes mellitus].
    Imura H; Yawata M; Endo J; Morita T; Hirakawa K
    Nihon Rinsho; 1967 Feb; 25(2):185-92. PubMed ID: 4293179
    [No Abstract]   [Full Text] [Related]  

  • 29. Pancreatic glucoregulatory hormones in cirrhosis of the liver: portal vein concentrations during intravenous glucose tolerance test and in response to a meal.
    Holst JJ; Burcharth F; Kühl C
    Diabete Metab; 1980 Jun; 6(2):117-27. PubMed ID: 6997101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of various physical factors on the immunoreactive insulin and somatotropic hormone levels in the blood of diabetes mellitus patients].
    Rakhmanova RT; Khusainova FS; Frenkel' ID
    Vopr Kurortol Fizioter Lech Fiz Kult; 1984; (1):33-6. PubMed ID: 6710915
    [No Abstract]   [Full Text] [Related]  

  • 31. Response of immunoreactive growth hormone, immunoreactive insulin, free fatty acids and blood sugar to exercise in obese patients and in normal subjects.
    ter Haar DJ; van Riet HG; Thijssen JH; Schwarz F
    J Endocrinol; 1969 Jan; 43(1):xi-xii. PubMed ID: 5789228
    [No Abstract]   [Full Text] [Related]  

  • 32. [Dynamics of concentration of insulin and growth hormone in blood serum in chronic liver diseases].
    Shlimovich PB; Sokolov IaA; Moskvichev AM
    Klin Med (Mosk); 1976 Jun; 54(6):90-5. PubMed ID: 972523
    [No Abstract]   [Full Text] [Related]  

  • 33. [Diabetes mellitus, blood lipids and atherosclerosis].
    Sil'nitskiĭ PA; Avenirova ZA; Alekseeva GG; Dzeranova NIa; Kniazevskaia EG
    Ter Arkh; 1972 Jul; 44(7):25-9. PubMed ID: 5069971
    [No Abstract]   [Full Text] [Related]  

  • 34. Insulin resistance and microalbuminuria are associated with microvascular disease in patients with cirrhosis.
    Krok KL; Milwalla F; Maheshwari A; Rankin R; Thuluvath PJ
    Liver Transpl; 2009 Sep; 15(9):1036-42. PubMed ID: 19718631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular disease in cirrhosis--a point-prevalence study in relation to glucose tolerance.
    Marchesini G; Ronchi M; Forlani G; Bugianesi E; Bianchi G; Fabbri A; Zoli M; Melchionda N
    Am J Gastroenterol; 1999 Mar; 94(3):655-62. PubMed ID: 10086647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies of hypothalamic control of somatotropin incretion in acromegaly].
    Liuzzi A; Chiodini PG; Botalla L; Cremascoli G; Tosi M
    Folia Endocrinol; 1973 Dec; 26(6):503-9. PubMed ID: 4801261
    [No Abstract]   [Full Text] [Related]  

  • 37. Glucose intolerance and insulin resistance in patients with liver disease. II. A study of etiologic factors and evaluation of insulin actions.
    Collins JR; Lacy WW; Stiel JN; Crofford OB
    Arch Intern Med; 1970 Oct; 126(4):608-14. PubMed ID: 5506964
    [No Abstract]   [Full Text] [Related]  

  • 38. [Study of gluco-lipid metabolism in relation to insulin and growth hormone in obese patients].
    Durán García S; Marañón Cabello A; Romero Bobillo E; Zurro Hernández J; Gómez López A; Romero E
    Rev Clin Esp; 1973 Nov; 131(3):205-12. PubMed ID: 4769038
    [No Abstract]   [Full Text] [Related]  

  • 39. Growth hormone in blood plasma of patients with liver cirrhosis.
    Kasperska-Czyzykowa T; Rogala H
    Acta Med Pol; 1978; 19(4):485-92. PubMed ID: 752250
    [No Abstract]   [Full Text] [Related]  

  • 40. [On the physiopathology of insulin production. II. Determination of immuno-reactive insulin (IRI) in obese subjects after oral administration of glucose].
    Peschle C; Rengo F; Saccà L; Ferrau O; Trimarchi F; Carducci A; Condorelli M
    Folia Endocrinol; 1969 Dec; 22(4):426-51. PubMed ID: 5409265
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.